A detailed history of Pathstone Holdings, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 89,558 shares of EW stock, worth $6.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
89,558
Previous 127,444 29.73%
Holding current value
$6.7 Million
Previous $11.8 Million 49.8%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$59.7 - $93.78 $2.26 Million - $3.55 Million
-37,886 Reduced 29.73%
89,558 $5.91 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $175,175 - $195,976
-2,078 Reduced 1.6%
127,444 $11.8 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $3.07 Million - $4.05 Million
42,336 Added 48.56%
129,522 $12.4 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $5.38 Million - $6.78 Million
87,186 New
87,186 $6.65 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.